Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia

Section on Neuropathology, Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.34). 07/2011; 31(30):11088-95. DOI: 10.1523/JNEUROSCI.1234-11.2011
Source: PubMed


GABA signaling molecules are critical for both human brain development and the pathophysiology of schizophrenia. We examined the expression of transcripts derived from three genes related to GABA signaling [GAD1 (GAD67 and GAD25), SLC12A2 (NKCC1), and SLC12A5 (KCC2)] in the prefrontal cortex (PFC) and hippocampal formation of a large cohort of nonpsychiatric control human brains (n = 240) across the lifespan (from fetal week 14 to 80 years) and in patients with schizophrenia (n = 30-31), using quantitative RT-PCR. We also examined whether a schizophrenia risk-associated promoter SNP in GAD1 (rs3749034) is related to expression of these transcripts. Our studies revealed that development and maturation of both the PFC and hippocampal formation are characterized by progressive switches in expression from GAD25 to GAD67 and from NKCC1 to KCC2. Previous studies have demonstrated that the former leads to GABA synthesis, and the latter leads to switching from excitatory to inhibitory neurotransmission. In the hippocampal formation, GAD25/GAD67 and NKCC1/KCC2 ratios are increased in patients with schizophrenia, reflecting a potentially immature GABA physiology. Remarkably, GAD25/GAD67 and NKCC1/KCC2 expression ratios are associated with rs3749034 genotype, with risk alleles again predicting a relatively less mature pattern. These findings suggest that abnormalities in GABA signaling critical to brain development contribute to genetic risk for schizophrenia.

1 Follower
54 Reads
  • Source
    • "More experiments are clearly needed to fully explore how activity-driven downregulation of KCC2 membrane stability may affect plasticity rules at glutamatergic synapses. In addition to activity-induced changes at the posttranslational level, KCC2 expression is also down-regulated in a variety of pathological conditions ranging from epilepsy (Rivera et al., 2004; Jin et al., 2005; Miles et al., 2012; Pallud et al., 2014), stroke (Jaenisch et al., 2010), to schizophrenia (Hyde et al., 2011) and autism (Tyzio et al., 2014). These conditions are associated with increased neuronal activity, which is often assumed to reflect reduced GABAergic signaling due to altered chloride extrusion. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Expression of the neuronal K/Cl transporter KCC2 is tightly regulated throughout development and by both normal and pathological neuronal activity. Changes in KCC2 expression have often been associated with altered chloride homeostasis and GABA signaling. However, recent evidence supports a role of KCC2 in the development and function of glutamatergic synapses through mechanisms that remain poorly understood. Here we show that suppressing KCC2 expression in rat hippocampal neurons precludes long-term potentiation of glutamatergic synapses specifically by preventing activity-driven membrane delivery of AMPA receptors. This effect is independent of KCC2 transporter function and can be accounted for by increased Rac1/PAK- and LIMK-dependent cofilin phosphorylation and actin polymerization in dendritic spines. Our results demonstrate that KCC2 plays a critical role in the regulation of spine actin cytoskeleton and gates long-term plasticity at excitatory synapses in cortical neurons
    Full-text · Article · Dec 2015 · The Journal of Neuroscience : The Official Journal of the Society for Neuroscience
    • "A point worth of emphasis is that CCCs are gaining an increasing amount of interest as potential drug targets (Gagnon et al. 2013; Töllner et al. 2014), especially with regard to the design of novel anticonvulsant drugs (Löscher et al. 2013a, 2013b). In this context, our data on the fetal onset of KCC2 expression in human supraspinal brain structures (see also Vanhatalo et al. 2005; Bayatti et al. 2008; Robinson et al. 2010; Hyde et al. 2011) refute the view (cf. Dzhala et al. 2005) that the poor efficacy of anticonvulsants in the term human neonate is attributable to a lack of KCC2. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Work on rodents demonstrated that steep upregulation of KCC2, a neuron-specific Cl(-) extruder of cation-chloride cotransporter (CCC) family, commences in supraspinal structures at around birth, leading to establishment of hyperpolarizing GABAergic responses. We describe spatiotemporal expression profiles of the entire CCC family in human brain. KCC2 mRNA was observed already at 10th postconceptional week (PCW) in amygdala, cerebellum, and thalamus. KCC2-immunoreactive (KCC2-ir) neurons were abundant in subplate at 18 PCW. By 25 PCW, numerous subplate and cortical plate neurons became KCC2-ir. The mRNA expression profiles of α- and β-isoforms of Na-K ATPase, which fuels cation-chloride cotransport, as well of tropomyosin receptor kinase B (TrkB), which promotes developmental upregulation of KCC2, were consistent with data from studies on rodents about their interactions with KCC2. Thus, in human brain, expression of KCC2 and its functionally associated proteins begins in early fetal period. Our work facilitates translation of results on CCC functions from animal studies to human and refutes the view that poor efficacy of anticonvulsants in the term human neonate is attributable to the lack of KCC2. We propose that perinatally low threshold for activation of Ca(2+)-dependent protease calpain renders neonates susceptible to downregulation of KCC2 by traumatic events, such as perinatal hypoxia ischemia.
    No preview · Article · Oct 2015 · Cerebral Cortex
    • "Dysfunctions of the GABAergic system, particularly linked to alterations of NKCC1/KCC2 ratio, have been recently associated to the development of mood), n ¼ 6–7 (CTRL, males), n ¼ 6–8 (PNS, females), and n ¼ 6–7 (PNS, males). orders and schizophrenia (Hyde et al., 2011;Price et al., 2009). Recent evidence indicates that in PNS offspring the expression of the a 4 subunit of GABA receptors is reduced both in the hippocampus and prefrontal cortex (Van denHove et al., 2013) likewise, Bdnf has been shown to be able to modulate the development of GABAergic interneurons (Berghuis et al., 2004;Marty, Berninger, Carroll, & Thoenen, 1996). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prenatal stress (PNS) is a risk factor for the development of neuropsychiatric disorders. This study was aimed at assessing, in a rodent model, changes in gene expression profiles and behavioral output as a result of PNS, during periadolescence, a critical developmental period for the onset of psychopathology. Social behavior was studied in a standardized social interaction paradigm and the expression of Brain-Derived Neurotrophic Factor (Bdnf), a marker of neuronal plasticity, and of inhibitory and excitatory mechanisms (Na(+) -K(+) -2Cl(-) and K(+) -Cl(-) cotransporters ratio, NKCC1/KCC2) was analyzed. Results indicate that PNS reduced Bdnf transcripts while increasing the NKCC1/KCC2 ratio, primarily in the hippocampus. In the prefrontal cortex, changes in Bdnf were found to be gender-dependent. These effects were accompanied by reduced levels of affiliative and investigative social behaviors. Interestingly, interaction with non-stressed subjects was able to improve sociality in PNS rats suggesting that the social environment could be exploited for therapeutic intervention. © 2015 Wiley Periodicals, Inc. Dev Psychobiol. © 2015 Wiley Periodicals, Inc.
    No preview · Article · Mar 2015 · Developmental Psychobiology
Show more